DiaMedica Therapeutics (DMAC) Accumulated Expenses (2018 - 2026)
DiaMedica Therapeutics' Accumulated Expenses came in at $3.67 million for Q2 2026, up 33.5% from $2.75 million a year earlier and up 56.7% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, DiaMedica Therapeutics' Accumulated Expenses was $3.55 million, down 18.4% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 32.6% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $4.35 million in FY2024 (+144.6%), $1.78 million in FY2023 (+30.2%), $1.37 million in FY2022 (+41.3%) and $966,000 in FY2021 (+11.8%).
- The Q2 2026 figure represents the highest quarterly Accumulated Expenses since Q4 2024.
- Year-over-year, Accumulated Expenses increased in six of the last eight quarters, with growth averaging 47.7%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q3 2024 (growth of 146.5%), and the weakest in Q3 2022 (a decline of 26.0%).
- Business Quant data shows DMAC's Accumulated Expenses at $2.34 million (Q1 2026), $3.55 million (Q4 2025) and $3.24 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | DiaMedica Therapeutics | 521.46 Mn | 311.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.67 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 3.55 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 956,000.00 |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 637,000.00 |
| Jun 30, 2022 | 894,000.00 |
| Mar 31, 2022 | 967,000.00 |
| Dec 31, 2021 | 966,000.00 |
| Sep 30, 2021 | 861,000.00 |
API Access
DiaMedica Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();